MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is indicated for the treatment of symptomatic moderate-to-severe or severe MR in patients who are deemed unsuitable for surgery or transcatheter edge-to-edge repair (TEER)...
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
MIDWAY 43 and MIDWAY 62 delivery catheters are designed to provide ideal tracking and a stable platform to support the delivery of various embolisation therapies in the neurovasculature.
Both the ACC and AHA scientific statements support the use of quantitative coronary plaque analysis to identify high-risk patients, enabling the immediate and appropriate initiation of preventive treatment.
Both the ACC and AHA scientific statements support the use of quantitative coronary plaque analysis to identify high-risk patients, enabling the immediate and appropriate initiation of preventive treatment.
The new guideline includes additions related to the role of clinicians with specialized expertise in guiding the care of adults with congenital heart disease; updates regarding mental health, physical activity, pregnancy and heart failure;...
The new guideline includes additions related to the role of clinicians with specialized expertise in guiding the care of adults with congenital heart disease; updates regarding mental health, physical activity, pregnancy and heart failure;...
When people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.
When people with prediabetes bring their blood glucose back into the normal range through lifestyle changes, their risk of heart attack, heart failure, and premature death is cut in half.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
The research suggests that CAVT, a technology designed to rapidly remove blood clots via microprocessor-controlled aspiration, has the potential to help reduce healthcare costs.
Muhammad Etiwy, MD; Adam N. Berman, MD, MPH; Michael H. Picard, MD; Chiara Fraccaro, MD, PhD; Nicole Karam, MD, PhD; Meagan M. Wasfy, MD, MPH; Yunong Zhao, MS; Magdi Zordok, MD; John Hsu, MD, MBA, MSCE; Jason H. Wasfy, MD, MPhil
The authors compared the outcomes of asymptomatic individuals with severe high gradient aortic stenosis and a left ventricular ejection fraction of 50% to 54% who received aortic valve replacement (AVR) with those who did not receive AVR.
The authors compared the outcomes of asymptomatic individuals with severe high gradient aortic stenosis and a left ventricular ejection fraction of 50% to 54% who received aortic valve replacement (AVR) with those who did not receive AVR.
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
MARLBOROUGH, Mass. and ALAMEDA, Calif. -- Boston Scientific Corporation and Penumbra, Inc., today announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in a cash and stock...
Using machine learning, the authors created a predictive tool to allow for individualized risk prediction for long-term atrial fibrillation recurrence following catheter ablation.
Using machine learning, the authors created a predictive tool to allow for individualized risk prediction for long-term atrial fibrillation recurrence following catheter ablation.
Miguel A. Martín-Arena, MD; Joaquín Vila-García, MD; Clara Ugueto-Rodrigo, MD; Cristina Contreras-Lorenzo, MD; Ricardo Martínez-González, MD; Carmen Labarta-Bello, MD; Guadalupe Buitrago Weiland, MD; Sandra Rosillo-Rodríguez, MD, PhD; Santiago Jiménez-Valero, MD; Raúl Moreno, MD, PhD
A 58-year-old man with a history of ascending aortic aneurysm repair underwent redo surgery because of severe aortic regurgitation. A mechanical valved conduit and a hemi-Cabrol graft from the left main coronary artery to the prosthetic...
A 58-year-old man with a history of ascending aortic aneurysm repair underwent redo surgery because of severe aortic regurgitation. A mechanical valved conduit and a hemi-Cabrol graft from the left main coronary artery to the prosthetic...
Ahmad Mustafa, MD; Denny Wang, BS ; Cole Dutton, BS; Arber Kodra, MD; Muhammad Abubakar Shakir, MD; Ythan Goldberg, MD; Mei Chau, MD; Shankar Thampi, MD; Priti Mehla, MD; Chapman Wei, MD; Shangyi Liu, MS; Michael Cinelli, MD; Bruce Rutkin, MD; Elana Koss, MD; Gregory Maniatis, MD; Alexander Iribarne, MD; Apurva Patel, MD; Sean Wilson, MD; Wally Omar, MD; Robert Kalimi, MD; Alan Hartman, MD; Jacob Scheinerman, MD; Chad Kliger, MD, MS
The authors evaluates early outcomes of facilitated transfemoral access compared to alternative access in patients with severe peripheral arterial disease.
The authors evaluates early outcomes of facilitated transfemoral access compared to alternative access in patients with severe peripheral arterial disease.
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
First-of-its-Kind, Multi-Specialty Clinical Initiative Across IC, EP, Endovascular, Aortic, and Neurovascular
BIRMINGHAM, Ala. — January 8, 2025 — Rampart, a Birmingham, Alabama–based medical device company redefining interventional...
Guste Cesnaite, MD; Ugne Stulpinaite, MD; Sigitas Cesna, MD, PhD
The authors report the case of a 9-year-old boy with repaired tetralogy of Fallot who underwent complete surgical correction with a GORE-TEX Cardiovascular Patch (W. L. Gore & Associates, Inc.) at 5 months old.
The authors report the case of a 9-year-old boy with repaired tetralogy of Fallot who underwent complete surgical correction with a GORE-TEX Cardiovascular Patch (W. L. Gore & Associates, Inc.) at 5 months old.
